Pharmacologic Profile of SCH 530348, a Novel Oral Antiplatelet Agent Selective for the Protease-Activated Receptor-1 (PAR-1)

被引：0
|
作者：
Chintala, Madhu [1 ]
Ahn, Ho-Sam [1 ]
Foster, Carolyn [1 ]
Agans, Jacqueline [1 ]
Boykow, George [1 ]
机构：
[1] Schering Plough Rsch Inst, Kenilworth, NJ USA
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [41] Activation of rat mast cells upon stimulation of protease-activated receptor (PAR-1)
    B. A. Umarova
    T. N. Dugina
    E. V. Shestakova
    E. Gluza
    S. M. Strukova
    Bulletin of Experimental Biology and Medicine, 2000, 129 : 314 - 317
  • [42] Pneumolysin mediates neutrophil: platelet aggregation via a P-selectin- and protease-activated receptor-1 (PAR-1)-dependent mechanism
    Feldman, Charles
    Nel, Jan G.
    Durandt, Chrisna
    Theron, Annette J.
    Tintinger, Gregory R.
    Richards, Guy A.
    Mitchell, Timothy J.
    Anderson, Ronald
    Pool, Roger
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [43] Thrombin-induced Ca2+ mobilization in human gingival fibroblasts is mediated by protease-activated receptor-1 (PAR-1)
    Tanaka, N
    Morita, T
    Nezu, A
    Tanimura, A
    Mizoguchi, I
    Tojyo, Y
    LIFE SCIENCES, 2003, 73 (03) : 301 - 310
  • [44] Activation of rat mast cells upon stimulation of protease-activated receptor (PAR-1)
    Umarova, BA
    Dugina, TN
    Shestakova, EV
    Gluza, E
    Strukova, SM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 129 (04) : 314 - 317
  • [45] Role of Matrix Metalloproteinase-1(MMP-1)/Protease-activated Receptor-1(PAR-1) Signaling Pathway in the Cervical Cancer Invasion
    Ning-xia SUN
    Qian ZHAO
    Chen YE
    Yan MA
    Wen LI
    Journal of Reproduction and Contraception, 2014, (01) : 18 - 25
  • [46] In vivo and in vitro effect of a new thrombin protease-activated receptor (PAR-1) antagonist
    Dumas, M.
    Nadal-Wollbold, F.
    Grelac, F.
    Aiach, M.
    Le Grand, B.
    Gaussem, P.
    Bachelot-Loza, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 86 - 86
  • [47] Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes:: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand
    Ubl, JJ
    Sergeeva, M
    Reiser, G
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 525 (02): : 319 - 330
  • [48] Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects
    Teddy Kosoglou
    Larisa Reyderman
    Renger G. Tiessen
    André A. van Vliet
    Robert R. Fales
    Robert Keller
    Bo Yang
    David L. Cutler
    European Journal of Clinical Pharmacology, 2012, 68 : 249 - 258
  • [49] Doxorubicin-induced Cardiac and Hepatic Toxicity is Mediated by Protease-activated Receptor 1 (PAR-1)
    Antoniak, Silvio
    Pawlinski, Rafal
    Mackman, Nigel
    CIRCULATION, 2010, 122 (21)
  • [50] Autoimmune Targeting of Protease Activated Receptor-1 (PAR-1) Deregulates VEGF and Disturbs Neoangiogenesis.
    Catar, R.
    Schramm, I.
    Simon, M.
    Wischnewski, O.
    Philippe, A.
    Kusch, A.
    Dragun, D.
    TRANSPLANTATION, 2014, 98 : 382 - 382
12345